Literature DB >> 28495569

Plasma Lipidomics of Healthy Japanese Adults Reveals Gender- and Age-Related Differences.

Keiko Maekawa1, Kazuo Okemoto2, Masaki Ishikawa1, Rieko Tanaka3, Yuji Kumagai3, Yoshiro Saito4.   

Abstract

Lipid metabolites in the blood are expected to be biomarker candidates to reflect disease states and responses to therapeutic drugs. However, their profiles are influenced by subject background, which may lead to confounding results. This study aimed to evaluate whether age and gender affect lipid metabolite levels in the plasma of healthy Japanese adults. Comprehensive lipidomic analysis was performed using liquid chromatography-mass spectrometry for overnight fasted volunteers consisting of 4 groups of 15 subjects each: young males (25-35 years), elderly males (55-64 years), young females (25-35 years), and elderly females (55-65 years). Of 326 detected lipids, none showed significant gender-associated differences in the young groups and 3 metabolites showed significant gender-associated differences in the elderly groups, suggesting that age has little impact on plasma lipid levels in Japanese subjects. We found age-associated differences in 111 (34%) and 115 (35%) metabolites in males and females, respectively, indicating that the subjects' age should be considered an important confounding factor for lipid biomarker exploration and validation studies in Japanese populations. These findings provide fundamental information on biomarker discovery, validation, and qualification processes in Japanese populations, and facilitate the evaluation of biomarker candidates found in other populations.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPLC; elderly; gender; lipids; mass spectrometry; metabolism

Mesh:

Substances:

Year:  2017        PMID: 28495569     DOI: 10.1016/j.xphs.2017.05.002

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Metabolic View on Human Healthspan: A Lipidome-Wide Association Study.

Authors:  Justin Carrard; Hector Gallart-Ayala; Denis Infanger; Tony Teav; Jonathan Wagner; Raphael Knaier; Flora Colledge; Lukas Streese; Karsten Königstein; Timo Hinrichs; Henner Hanssen; Julijana Ivanisevic; Arno Schmidt-Trucksäss
Journal:  Metabolites       Date:  2021-04-30

2.  Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.

Authors:  Kai Guo; Masha G Savelieff; Amy E Rumora; Fadhl M Alakwaa; Brian C Callaghan; Junguk Hur; Eva L Feldman
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

3.  MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines.

Authors:  Bo Burla; Makoto Arita; Masanori Arita; Anne K Bendt; Amaury Cazenave-Gassiot; Edward A Dennis; Kim Ekroos; Xianlin Han; Kazutaka Ikeda; Gerhard Liebisch; Michelle K Lin; Tze Ping Loh; Peter J Meikle; Matej Orešič; Oswald Quehenberger; Andrej Shevchenko; Federico Torta; Michael J O Wakelam; Craig E Wheelock; Markus R Wenk
Journal:  J Lipid Res       Date:  2018-08-16       Impact factor: 5.922

4.  Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver.

Authors:  David Balgoma; Sofia Zelleroth; Alfhild Grönbladh; Mathias Hallberg; Curt Pettersson; Mikael Hedeland
Journal:  Metabolomics       Date:  2020-01-10       Impact factor: 4.290

5.  Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis.

Authors:  Sock Hwee Tan; Hiromi W L Koh; Jing Yi Chua; Bo Burla; Ching Ching Ong; Li San Lynette Teo; Xiaoxun Yang; Peter I Benke; Hyungwon Choi; Federico Torta; A Mark Richards; Markus R Wenk; Mark Y Chan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-11-23       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.